1990
DOI: 10.1002/j.1460-2075.1990.tb08218.x
|View full text |Cite
|
Sign up to set email alerts
|

Synergism in ternary complex formation between the dimeric glycoprotein p67SRF, polypeptide p62TCF and the c-fos serum response element.

Abstract: Transcriptional regulation of the c‐fos proto‐oncogene requires the serum response element (SRE) which is complexed by a multi‐protein assembly observed both in vitro and in vivo. Two protein factors, p67SRF and p62TCF (previously called p62), are required to interact with the SRE for efficient induction of c‐fos by serum. By quantitative band shift electrophoresis we measure at least a 50‐fold increase in SRE affinity for p67SRF/p62TCF over p67SRF alone. Stoichiometrically we determine that the ternary comple… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
100
1

Year Published

1991
1991
2000
2000

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 148 publications
(109 citation statements)
references
References 51 publications
8
100
1
Order By: Relevance
“…Elk-1 is one of the main nuclear targets of activated MAPK/ERK and has been shown to be newly phosphorylated on Ser 383 and Ser 389 by growth factors (Marais et al, 1993), leading to SRE-driven gene transcription in cell cultures (for review, see Wasylyk et al, 1998). The SRE, together with flanking DNA sequences, serves as a site of assembly of multiprotein complexes, including a dimer of the serum response factor (Treisman, 1986;Norman et al, 1988;Schröter et al, 1990) and a protein of the ternary complex factor family, such as Elk-1 (for review, see Treisman, 1995), and this site is present in the promoter region of many IEGs, including zif268. Our results, which show that inhibition of MAPK/ERK phosphorylation and the resulting inhibition of Elk-1 prevents the transcriptional activation of zif268, support the model that activation of the MAPK/ERK signaling pathway targets nuclear Elk-1 to control SRE-mediated gene expression in LTP.…”
Section: Discussionmentioning
confidence: 99%
“…Elk-1 is one of the main nuclear targets of activated MAPK/ERK and has been shown to be newly phosphorylated on Ser 383 and Ser 389 by growth factors (Marais et al, 1993), leading to SRE-driven gene transcription in cell cultures (for review, see Wasylyk et al, 1998). The SRE, together with flanking DNA sequences, serves as a site of assembly of multiprotein complexes, including a dimer of the serum response factor (Treisman, 1986;Norman et al, 1988;Schröter et al, 1990) and a protein of the ternary complex factor family, such as Elk-1 (for review, see Treisman, 1995), and this site is present in the promoter region of many IEGs, including zif268. Our results, which show that inhibition of MAPK/ERK phosphorylation and the resulting inhibition of Elk-1 prevents the transcriptional activation of zif268, support the model that activation of the MAPK/ERK signaling pathway targets nuclear Elk-1 to control SRE-mediated gene expression in LTP.…”
Section: Discussionmentioning
confidence: 99%
“…The interaction of SRF with accessory factors has been demonstrated in a number of systems. Studies of c-fos gene regulation has led to the identification of several accessory factors, including SAP-1, Elk-1, and Phox-1 (48,(63)(64)(65). These factors appear to be expressed ubiquitously and together with SRF potentiate the transcriptional activity of the c-fos gene, although the exact regulatory mechanisms are somewhat distinct.…”
Section: Mnkx3-1 and Srf Coactivate ␥-Sm Actin Promotermentioning
confidence: 99%
“…The mitogen stimulation of c-fos transcription is a paradigm for a gene regulated via the Ras pathway. The SRE (Serum Response Element) in the c-fos promoter is continuously bound by two nuclear proteins SRF and Elk/TCF (Herrera et al, 1989;KoÈ nig, 1991;Norman et al, 1988;Prywes and Roeder, 1987;SchroÈ ter et al, 1990;Shaw et al, 1989;Treisman, 1987). Upon Ras activation Elk1 is rapidly phosphorylated by MAPK-1 and MAPK-2 (also called ERK1 and ERK2) resulting in a strong increase in its transcriptional activity (Hipskind et al, 1994;Prywes et al, 1988;Zinck et al, 1993).…”
Section: Introductionmentioning
confidence: 99%